During the last session, Altimmune Inc (NASDAQ:ALT)’s traded shares were 2.2 million, with the beta value of the company hitting 0.16. At the end of the trading day, the stock’s price was $7.08, reflecting an intraday loss of -6.47% or -$0.49. The 52-week high for the ALT share is $14.84, that puts it down -109.6 from that peak though still a striking 70.48% gain since the share price plummeted to a 52-week low of $2.09. The company’s market capitalization is $501.97M, and the average trade volume was 4.73 million shares over the past three months.
Altimmune Inc (NASDAQ:ALT) trade information
Altimmune Inc (ALT) registered a -6.47% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -6.47% in intraday trading to $7.08, hitting a weekly high. The stock’s 5-day price performance is 0.57%, and it has moved by -17.00% in 30 days. Based on these gigs, the overall price performance for the year is 28.26%.
Altimmune Inc (ALT) estimates and forecasts
Statistics show that Altimmune Inc has underperformed its competitors in share price, compared to the industry in which it operates. Altimmune Inc (ALT) shares have gone up 230.84% during the last six months, with a year-to-date growth rate less than the industry average at -6.29% against 10.10. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 5.00% this quarter and then drop -18.80% in the quarter after that. In the rating firms’ projections, revenue will increase 9,681.70% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 35.74%. While earnings are projected to return -4.22% in 2024.
ALT Dividends
Altimmune Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
